7:15 am Conference Registration & Welcome Coffee

8:15 am Chair’s Opening Remarks

• Carl Barrett Vice President, Translational Science, Oncology, AstraZeneca

Current Application For Spatial Biology In Immuno-Oncology

8:30 am Spatial Biology Tools Paving the Way to a Brighter Clinical Future

• Tom McNicholas Manager, Product Technology & Strategy, Leica Biosystems
• David Ferber Senior Medical Science Liaison, Leica Biosystems
• Carl Barrett Vice President, Translational Science, Oncology, AstraZeneca
• Dr Brooke Howitt Associate Professor of Pathology, Stanford University School of Medicine

9:15 am Incorporating Spatial Biology to the Clinic

• Carl Barrett Vice President, Translational Science, Oncology, AstraZeneca

9:45 am Unlocking Novel Phenotypes From Multiplex with AI

• Andrew Fisher Principal Scientist, Digital Pathology, Bristol Myers Squibb

10:15 am Morning Break & Speed Networking

11:15 am Spatial Biology to Improve Clinical Trial Outcomes

• Tom Turi Chief Scientific Officer, Flagship Biosciences

11:45 am CASE STUDY: Uncovering Spatial Proteomic Predictors of Breast Tumor Progression Using Multiplexed Ion Beam Imaging

• Tyler Risom Senior Scientist, Research Pathology, Genentech

12:15 pm The Latest Advancements in Spatial Genomics from 10x Genomics

• Michael Schnall-Levin Chief Technology Officer and Founding Scientist, 10x Genomics

12:45 pm Lunch Break

Enhancing Biomarker Discovery

1:45 pm Applying the Spatial Approach to Progress Immuno-Oncology and Predictive Biomarkers

• Travis Hollmann Scientific Director, Translational Medicine, Bristol Myers Squibb

2:15 pm The Medical Immuno Oncologist and Research Pathologist View on Spatial Biology

• Houssein Sater, MD Physician Scientist Immuno-Oncology, Regional Research Director for the Cancer Institute, Cleveland Clinic Florida

2:45 pm PANEL DISCUSSION: Predictive Biomarkers in the Age of Spatial Biology

• Travis Hollmann Scientific Director, Translational Medicine, Bristol Myers Squibb
• Aarti Tarkar PhD/MBA Associate Director, Experimental Medicine Unit, GlaxoSmithKline
• Houssein Sater, MD Physician Scientist Immuno-Oncology, Regional Research Director for the Cancer Institute, Cleveland Clinic Florida
• Suzanne Coberly Scientific Senior Director, Translational Pathology, Bristol Myers Squibb

Developing A Robust Data Analysis Pipeline

3:30 pm Afternoon Networking Break & Poster Session

4:15 pm Fusing Spatial Biology and Phenotype Data

• David Reiss Computational Biology and Digital Pathology, Bristol Myers Squibb

4:45 pm CASE STUDY: Using Spatial Biology to Understand the Tumor Microenvironment to Support Antibody Therapeutic Development

• Omar Jabado Principal Scientist, Translational Sciences, Genmab

5:15 pm Roundtable Discussion:

• Colles Price Principal Scientist, Takeda Oncology
• Sandra Wiley Director of Translational Sciences, MEI Pharma
• Lauri Diehl Executive Director, Research Pathology, Gilead

5:45 pm Chair’s Closing Remarks

• Carl Barrett Vice President, Translational Science, Oncology, AstraZeneca

6:00 pm Drinks Reception